MedPath

Clinical Comparison of 4 Daily Disposable Soft Contact Lenses

Not Applicable
Completed
Conditions
Refractive Error
Interventions
Device: verofilcon A contact lenses
Device: senofilcon A contact lenses
Device: stenfilcon A contact lenses
Device: etafilcon A contact lenses
Registration Number
NCT03349632
Lead Sponsor
Alcon Research
Brief Summary

The purpose of this study is to obtain on-eye performance data to inform contact lens product development and to further evaluate product performance in the intended population.

Detailed Description

The expected duration of subject participation in the study is approximately 20 days with 3 scheduled visits. Each subject will evaluate the test contact lenses compared to 1 of 3 commercially available contact lenses.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • Able to understand and must sign an approved Informed Consent Form
  • Successfully wears daily disposable spherical soft contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months
  • Best Corrected Visual Acuity of 20/25 Snellen or better in each eye
  • Willing to stop wearing habitual contact lenses for the duration of study participation
  • Other protocol-defined inclusion criteria may apply
Exclusion Criteria
  • Any eye condition, surgery, disease, or use of medication that contraindicates contact lens wear, as determined by the Investigator.
  • Routinely sleeps in habitual contact lenses
  • Currently wears Oasys 1-Day, MyDay, or Moist contact lenses
  • Other protocol-defined exclusion criteria may apply

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
DD T2/Oasys 1-Dayverofilcon A contact lensesVerofilcon A contact lenses and senofilcon A contact lenses worn in both eyes, each product, for 1 week on a daily wear basis, as randomized
DD T2/Oasys 1-Daysenofilcon A contact lensesVerofilcon A contact lenses and senofilcon A contact lenses worn in both eyes, each product, for 1 week on a daily wear basis, as randomized
DD T2/MyDayverofilcon A contact lensesVerofilcon A contact lenses and stenfilcon A contact lenses worn in both eyes, each product, for 1 week on a daily disposable basis, as randomized
DD T2/MyDaystenfilcon A contact lensesVerofilcon A contact lenses and stenfilcon A contact lenses worn in both eyes, each product, for 1 week on a daily disposable basis, as randomized
DD T2/Moistverofilcon A contact lensesVerofilcon A contact lenses and etafilcon A contact lenses worn in both eyes, each product, for 1 week on a daily disposable basis, as randomized
DD T2/Moistetafilcon A contact lensesVerofilcon A contact lenses and etafilcon A contact lenses worn in both eyes, each product, for 1 week on a daily disposable basis, as randomized
Primary Outcome Measures
NameTimeMethod
Overall Quality of VisionDay 8, each product

Overall quality of vision was collected binocularly and rated on a 10-point scale with 1 = poor to 10 = excellent. Subjects were asked "Thinking back over the last week, please rate our study lenses. Rate eyes together." No formal hypotheses was conducted; hence no inferential testing was performed.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Alcon Investigative Site

🇺🇸

Johns Creek, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath